Calendar Alterity Therapeutics Limited Nasdaq

Equities

ATHE

US02155X2053

Market Closed - Nasdaq 04:30:00 2024-04-24 pm EDT 5-day change 1st Jan Change
2.33 USD +9.39% Intraday chart for Alterity Therapeutics Limited +15.92% -6.43%

Chart calendar Alterity Therapeutics Limited

2b466ac6199.Kqvj0hy341yzlyjyXKvg7aFiBn6oWyLdpQvU5Rliyjc.XuXRjUzTixT901qFPsKmg8AQbjieGnS35n2jrlgV_AR-37Hqed-HcYTHWw~0e54abb6cbf97789813de47ca0c979d4

Upcoming events on Alterity Therapeutics Limited

2025-02-26 Q2 2025 Earnings Release (Projected)
2026-02-25 Q2 2026 Earnings Release (Projected)
2027-03-03 Q2 2027 Earnings Release (Projected)

Past events on Alterity Therapeutics Limited

2024-04-16 01:45 pm American Academy of Neurology Meeting
2024-04-15 07:30 pm American Academy of Neurology Meeting
2024-04-14 01:45 pm American Academy of Neurology Meeting
2024-04-11 Extraordinary Shareholders Meeting
2024-02-28 12:07 am Q2 2024 Earnings Release
2024-02-01 08:30 pm ShareCafe Hidden Gems Conference
2023-12-28 06:00 pm Extraordinary Shareholders Meeting
2023-12-05 05:00 pm Primates ATH434 Efficacy Data Results Call
2023-11-29 Future of Parkinson Disease Conference
2023-11-28 05:00 pm Annual General Meeting
2023-10-29 07:14 pm September 2023 Sales and Revenue Release - Activities Report
2023-08-28 07:00 am Parkinson Disease and Movement Disorders International Congress - Abstract Number:181
2023-08-28 07:00 am Parkinson Disease and Movement Disorders International Congress - Abstract Number:162
2023-06-21 08:30 pm MST Access Rare Diseases Rich ReturnsForum
2023-05-22 11:00 am Shareholder Access and Retail Engagement Conference - Fireside Chat
2023-04-27 12:29 am March 2023 Sales and Revenue Release - Activities Report
2023-03-09 08:30 pm ShareCafe Hidden Gems Presentation
2023-02-27 09:18 pm Q2 2023 Earnings Release
2023-01-31 07:25 am December 2022 Sales and Revenue Release - Activities Report
2022-11-10 Annual General Meeting

Annual results

Fiscal PeriodJune 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


3,29
2,77
18.68%
3,53
3,50
0.76%
2,55
3,09
-17.31%

1,87

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-10,8
-11,0
2.43%
-10,4
-10,9
4.49%
-9,32
-11,1
15.99%

-8,69

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-11,2
-11,9
5.69%
-8,79
-10,3
14.99%
-8,90
-11,0
19.32%

-8,84

Net income
Million USD
Released
Forecast
Spread
-7,39


-11,2
-11,9
5.69%
-8,84
-10,3
14.53%
-8,97
-11,0
18.71%

-8,84

EPS
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date30/08/2031/08/2131/08/2231/08/23-

Quarterly results

Fiscal PeriodJune 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million USD
Released
Forecast
Spread



1,88
1,39
35.26%



1,90
2,87
-33.69%
1,62
1,82
-11.14%



1,31
0,96
37.11%

0,91

EBIT
Million USD
Released
Forecast
Spread



-5,24
-5,61
6.7%



-5,19
-5,62
7.73%
-5,55
-5,10
-8.72%
-3,98
-5,65
29.53%
-4,17
-4,24
1.79%

-4,45

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-4,93
-5,73
13.95%



-4,26
-5,77
26.08%
-5,35
-5,21
-2.77%



-4,23
-4,32
2.06%

-4,52

Net income
Million USD
Released
Forecast
Spread
-6,81


-4,93
-5,73
13.95%
-4,78


-4,31
-5,77
25.24%
-5,42
-5,21
-4.12%



-4,23
-4,32
2.06%

-4,52

Announcement Date25/02/2131/08/2128/02/2231/08/2228/02/2331/08/2329/02/24-

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

  1. Stock Market
  2. Equities
  3. ATH Stock
  4. ATHE Stock
  5. Calendar Alterity Therapeutics Limited